Published in Cardiovascular Week, August 16th, 2004
Prior-year results reflect legacy Pfizer, as well as legacy Pharmacia subsequent to the April 16, 2003, close of the Pharmacia acquisition.
"Pfizer's financial results in the second quarter reflect the company's fundamental soundness and resilience in the face of dynamic market conditions," said Hank McKinnell, chairman and chief executive officer.
"Our bottom line remains unaffected by these conditions. While a more-challenging business environment, marked by new competition and the effects of less- favorable foreign-exchange rates than we anticipated, led us to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.